Cadila Healthcare stock touched an intraday high of Rs 452.45, rising 7.13% Cadila Healthcare share price touched a fresh 52 week high in early trade today after Zydus Cadila said it … Get all the information on mutual fund schemes and the names of institutions which invested in a company. Pidilite Ind 1,731.80 102.15. Cadila Healthcare shares up 3% on plans to launch COVID-19 vaccine by March 2021 Higher the market capitalization of a company, higher the rank it is assigned. Its current market capitalisation stands at Rs 46319.23 Cr. Stable Share Price: CADILAHC is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 5% a week. Latest Share Price and Events. Note : Support and Resistance level for the Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. represents current trend. Nov 12 2020 11:11 AM, Friends - WAtch out IT and Pharma stocks in the first half where as NBFC may remain weak, Pharma and IT may outperform this morning! *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange. Note : Support and Resistance level for the week, calculated 458.80 29.6. Cadila Healthcare Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. | This or medium without express writtern permission of moneycontrol.com is prohibited. Note : Support and Cadila Healthcare Ltd. was incorporated in the year 1995. By Jason Junior On Nov 27, 2020. Morning Call on Cadila rocked, hope everyone has booked good profit :) Nov 27, 13:39. Get Cadila Healthcare detailed stock quotes and technical charts for Cadila Health. As on 30-09-2020, the company has a total of 1,023,742,600 shares outstanding. Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 5967.70 Crore to Sales Value (94.01 % of Total Sales), Other Operating Revenue which contributed Rs 205.40 Crore to Sales Value (3.23 % of Total Sales) and Export Incentives which contributed Rs 174.30 Crore to Sales Value (2.74 % of Total Sales)for the year ending 31-Mar-2020.For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 3820.00 Crore, up 4.95 % from last quarter Sales of Rs 3639.90 Crore and up 17.75 % from last year same quarter Sales of Rs 3244.20 Crore Company has reported net profit after tax of Rs 423.60 Crore in latest quarter.The company’s top management includes Dr.Sharvil P Patel, Mr.Apurva S Diwanji, Mr.Bhadresh Shah, Mr.Ganesh N Nayak, Mr.Mukesh M Patel, Mr.Pankaj R Patel, Ms.Dharmishta N Rawal, Ms.Nitin R Desai. Antony Waste Handling IPO subscription status, Closing Cash & Cash Equivalent Growth (%), Book closure from Aug 14, 2020 to Aug 21, 2020, Bonus Ratio: 1 share(s) for every 2 shares held, Bonus Ratio: 1 share(s) for every 1 shares held. Benchmarks . St. Xaviers Corne","address3":"Off C. G. Road, Ellisbridge, Navrangpura","address4":"","telephone":"079-26465179","fax":"079-26465179","email":"ahmedabad@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Ahmedabad","state":"Gujarat","pincode":"380009"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"532321","nseId":"CADILAHC","series":"EQ","isinid":"INE010B01027"}}}. For the year ending March 2020 Cadila Healthcare has declared an equity dividend of 350.00% amounting to Rs 3.5 per share. It offers therapeutic proteins, monoclonal antibodies, and antibody-drug conjugates. Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. #cadila cash -positional 14.12.2020 looks good above 476.10 & more above 481 stoploss 460 target 540/600 cmp 470 MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. Company Announcement Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 09, 2020, titled "Zydus granted Fast Track Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis … [{"heading":"Revenue","data":[{"year":"Sep 2019","value":"3366","formattedValue":"3,366 Cr"},{"year":"Dec 2019","value":"3638","formattedValue":"3,638 Cr"},{"year":"Mar 2020","value":"3752","formattedValue":"3,752 Cr"},{"year":"Jun 2020","value":"3639","formattedValue":"3,639 Cr"},{"year":"Sep 2020","value":"3820","formattedValue":"3,820 Cr"}]},{"heading":"Net Profit","data":[{"year":"Sep 2019","value":"82","formattedValue":"82 Cr"},{"year":"Dec 2019","value":"364","formattedValue":"364 Cr"},{"year":"Mar 2020","value":"413","formattedValue":"413 Cr"},{"year":"Jun 2020","value":"469","formattedValue":"469 Cr"},{"year":"Sep 2020","value":"423","formattedValue":"423 Cr"}]},{"heading":"EPS","data":[{"year":"Jun 2019","value":"1.05","formattedValue":"1.05"},{"year":"Mar 2019","value":"2.97","formattedValue":"2.97"},{"year":"Dec 2020","value":"3.83","formattedValue":"3.83"},{"year":"Jun 2020","value":"4.62","formattedValue":"4.62"},{"year":"Mar 2020","value":"4.43","formattedValue":"4.43"}]}], {"success":1,"data":{"address":{"address1":"Zydus Corporate Park, Scheme No.63,","address2":"Survey No. Cadila Healthcare Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. Majority of profits last year were disbursed as dividends to shareholders. Nifty 13,760.55 19.85. Get market analysis, live market index, technical information, stock research, historical information & graphs. Check out why Cadila Health share price is up today. *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore. Shares of Cadila Healthcare traded 0.13 per cent up in trade at 10:04 am on Friday . All other things being equal, higher the dividend yield of the stock, the better it is for investors. Book value is also known as Net Asset Value of a company. Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Positional and Intraday Trading Calls basis Noiseless Chart, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, (OI Nov 13 2020 04:11 PM, Cadila Healthcare shares up 4% on completion of phase-II trial of COVID vaccine Cadilahc financial results, Cadilahc shareholding, Cadilahc annual reports, Cadilahc pledge, Cadilahc insider trading and compare with peer companies. Note : Support and Resistance level for the Find market predictions, CADILAHC financials and market news. St. Xaviers Corne, Your feedback matters! Note : Support and Resistance level for the month, calculated based on price range of the previous trading week. The company’s top management includes Dr.Sharvil P Patel, Mr.Apurva S Diwanji, Mr.Bhadresh Shah, Mr.Ganesh N Nayak, Mr.Mukesh M Patel, Mr.Pankaj R Patel, Ms.Dharmishta N Rawal, Ms.Nitin R Desai. Vaishnodevi Circle,Ahmedabad, Gujarat - 382481, Cadila Healthcare Ltd. share price moved up by 1.27% from its previous close of Rs 469.05. Ltd.","address1":"506 - 508, 5th Floor, Amaranth Business Complex I ","address2":"Beside Gala Business Center, Nr. 536, Khoraj (Gandhinagar),Nr. 536, Khoraj (Gandhinagar),,Nr. Adani Enterpr. NSE Gainer-Large Cap . Zydus Corporate Park, Scheme No.63,,Survey No. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions. Nov 27, 09:38. Is the company as good as it looks? Higher the score, better the financials of the company. In other words, at today's prices, investors are paying ₹20.56 for every ₹1 in prior year profit. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. By using this site, you agree to the Terms of Service and Privacy Policy. Shares of Cadila Healthcare traded 0.13 per cent up in trade at 10:04 am on Friday . Stock market update: 97 stocks hit 52-week highs on NSE, Stock market update: 160 stocks hit 52-week highs on NSE, Stock market update: Pharma stocks advance; Cadila Healthcare leaps 6%, Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation, Compliances-Reg. Keep a tab on promoter holdings along with pledge details. Tell us what we got right and what we didn’t? The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India. In 2015 the company acquired another Indian pharmaceutical company called German Remedies. You will now receive notification when someone reply to this message. Price target in 14 days: 504.931 INR. It offers therapeutic proteins, monoclonal antibodies, and antibody-drug conjugates. FEATURED FUNDS ★★★★ ★ Axis Long Term Equity Direct Plan-Growth. 5, Thank you Mani Sir :) A healthy social and MMB environment will lead to a healthy mind and a healthy body it`s a situation that is conducive for wealth creation ideas :).